James V. Heck
Board of advisory
Infectious Diseases
Cempra
India
Biography
Dr. James Heck joined Merck Research Laboratories in 1976, where he rose through the ranks to Vice President, Medicinal Chemistry. For eight years he guided a research team of approximately 250 scientists, who were responsible for moving more than 15 candidates into development. Among these was Cancidas, a systemic antifungal agent that was approved by the FDA in 2001. He retired from Merck at the end of 2006, and currently maintains a consulting practice with 13 clients. Dr. Heck received his Ph.D. in Organic Chemistry from Harvard University in 1976 after working four years in the laboratories of Professor R.B. Woodward.
Research Interest
Dr. James Heck joined Merck Research Laboratories in 1976, where he rose through the ranks to Vice President, Medicinal Chemistry. For eight years he guided a research team of approximately 250 scientists, who were responsible for moving more than 15 candidates into development. Among these was Cancidas, a systemic antifungal agent that was approved by the FDA in 2001. He retired from Merck at the end of 2006, and currently maintains a consulting practice with 13 clients. Dr. Heck received his Ph.D. in Organic Chemistry from Harvard University in 1976 after working four years in the laboratories of Professor R.B. Woodward.
